Related references
Note: Only part of the references are listed.Addition of Rituximab to High-Dose Methotrexate-Based Chemotherapy Improves Survival of Adults with Burkitt Lymphoma/Leukemia
Dino Dujmovic et al.
ACTA HAEMATOLOGICA (2012)
Intensive short-term chemotherapy regimen induces high remission rate (over 90%) and event-free survival both in children and adult patients with advanced sporadic Burkitt lymphoma/leukemia
Giuseppe Todeschini et al.
AMERICAN JOURNAL OF HEMATOLOGY (2012)
RD-CODOX-M/IVAC with rituximab and intrathecal liposomal cytarabine in adult Burkitt lymphoma and 'unclassifiable' highly aggressive B-cell lymphoma
Gaetano Corazzelli et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Pooled analysis of AIDS malignancy consortium trials evaluating rituximab plus CHOP or infusional EPOCH chemotherapy in HIV-associated non-Hodgkin lymphoma
Stefan K. Barta et al.
CANCER (2012)
Advanced Stage, Increased Lactate Dehydrogenase, and Primary Site, but Not Adolescent Age (≥ 15 Years), Are Associated With an Increased Risk of Treatment Failure in Children and Adolescents With Mature B-Cell Non-Hodgkin's Lymphoma: Results of the FAB LMB 96 Study
Mitchell S. Cairo et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Evaluation of the addition of rituximab to CODOX-M/IVAC for Burkitt's lymphoma: a retrospective analysis
J. A. Barnes et al.
ANNALS OF ONCOLOGY (2011)
Rituximab in combination with CODOX-M/IVAC: a retrospective analysis of 23 cases of non-HIV related B-cell non-Hodgkin lymphoma with proliferation index > 95%
Sajir G. Mohamedbhai et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Population based study of prognostic factors and treatment in adult Burkitt lymphoma: a Swedish Lymphoma Registry study
Tove Wasterlid et al.
LEUKEMIA & LYMPHOMA (2011)
Excellent immunological recovery following CODOX-M/IVAC, an effective intensive chemotherapy for HIV-associated Burkitt's lymphoma
Silvia Montoto et al.
AIDS (2010)
Controversies in the treatment of Burkitt lymphoma in AIDS
Ariela Noy
CURRENT OPINION IN ONCOLOGY (2010)
High-dose chemotherapy and immunotherapy in adult Burkitt lymphoma - Comparison of results in human immunodeficiency virus-infected and noninfected patients
Albert Oriol et al.
CANCER (2008)
Intensive chemotherapy regimen (LMB86) for St Jude stage IV AIDS-related Burkitt lymphoma/leukemia:: a prospective study
Lionel Galicier et al.
BLOOD (2007)
Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia
DA Thomas et al.
CANCER (2006)
Intensive chemotherapy with and without cranial radiation for Burkitt leukemia and lymphoma - Final results of cancer and leukemia group B study 9251
DA Rizzieri et al.
CANCER (2004)
Share Paper
